Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
It imports various medicines to India from different sources across the globe.
Financial Results:
Novartis India Ltd reported Revenues for Q1FY24 of ₹91.00 Crores down from ₹121.00 Crore year on year, a fall of 24.79%.
Total Expenses for Q1FY24 of ₹75.00 Crores down from ₹90.00 Crores year on year, a fall of 16.67%.
Consolidated Net Profit of ₹20.00 Crores down 61.54% from ₹52.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹8.21, down 61.29% from ₹21.21 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.